Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Level of 25-hydroxyvitamin D and vitamin D receptor in diabetic foot ulcer and factor associated with diabetic foot ulcers

Fig. 3

The biomarker potential of serum 25(OH)VD for DFU and DFO and that of T-VDR for DFO. A Serum 25(OH)VD distinguished DFU patients from controls with area under curve (AUC) of 0.821 (95% CI: 0.754–0.886, P < 0.001). B Serum 25(OH)VD distinguished DFO patients from DFU patients (AUC: 0.786; 95%CI: 0.643–0.867, P < 0.001). C T-VDR distinguished DFO patients from DFU patients (AUC: 0.703; 95%CI: 0.618–0.853, P < 0.001). 25(OH)VD 25-hydroxyvitamin D, DFU diabetic foot ulcer, DFO diabetic foot osteomyelitis, T-VDR Vitamin D receptor mRNA expression in wound margin tissue. [Color figure can be viewed at wileyonlinelibrary.com]

Back to article page